Taken together, we identified hypoxia-induced mitophagy as a novel mechanism to regulate TRAIL sensitivity in oxygen-deprived colorectal cancer cells and characterized cancer cell intrinsic and extrinsic approaches for re-sensitization to TRAIL-based anti-cancer therapy (summarized in Figure 9). This evidence concerns the gene TNFSF10 and cancer.